Filteren op Last updated date SelectNaVoorFrom - To Date Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Laat dit veld leeg Filter Resultaten (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 8-9 September 2020 11 september 2020NewsVeterinaryMedicinesVaccines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 31 August - 3 September 2020 4 september 2020NewsHumanPharmacovigilanceReferrals PRAC recommends revoking marketing authorisation of ulipristal acetate for uterine fibroids 4 september 2020NewsHumanMedicinesReferrals EMA starts review of dexamethasone for treating adults with COVID-19 requiring respiratory support 2 september 2020NewsHumanCOVID-19MedicinesReferrals EMA receives application for marketing authorisation of Dexamethasone Taw for COVID-19 2 september 2020NewsHumanCOVID-19Medicines Communication@EMA – how are we doing? 10 augustus 2020NewsCorporate Global regulatory workshop on COVID-19 therapeutics #2: agreement on acceptable endpoints for clinical trials 31 juli 2020NewsHumanCOVID-19Research and development Global regulatory workshop on COVID-19 real-world evidence and observational studies 31 juli 2020NewsHumanCOVID-19Research and development Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2020 24 juli 2020NewsHumanCOVID-19BiosimilarsGeneric and hybrid medicinesMedicinesMedicines for use outside the EU Authorised uses of cancer medicine Yondelis unchanged following review of new data 24 juli 2020NewsHumanReferrals 1 … 81 82 83 84 85 Page 85 of 384 86 87 88 89 … 384
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 8-9 September 2020 11 september 2020NewsVeterinaryMedicinesVaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 31 August - 3 September 2020 4 september 2020NewsHumanPharmacovigilanceReferrals
PRAC recommends revoking marketing authorisation of ulipristal acetate for uterine fibroids 4 september 2020NewsHumanMedicinesReferrals
EMA starts review of dexamethasone for treating adults with COVID-19 requiring respiratory support 2 september 2020NewsHumanCOVID-19MedicinesReferrals
EMA receives application for marketing authorisation of Dexamethasone Taw for COVID-19 2 september 2020NewsHumanCOVID-19Medicines
Global regulatory workshop on COVID-19 therapeutics #2: agreement on acceptable endpoints for clinical trials 31 juli 2020NewsHumanCOVID-19Research and development
Global regulatory workshop on COVID-19 real-world evidence and observational studies 31 juli 2020NewsHumanCOVID-19Research and development
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2020 24 juli 2020NewsHumanCOVID-19BiosimilarsGeneric and hybrid medicinesMedicinesMedicines for use outside the EU
Authorised uses of cancer medicine Yondelis unchanged following review of new data 24 juli 2020NewsHumanReferrals